We are live on ! Find out more
DSCI

Derma Sciences
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

70 hedge funds and large institutions have $176M invested in Derma Sciences in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.29% less ownership

Funds ownership: 86.03% → 83.74% (-2.3%)

4% less funds holding

Funds holding: 73 → 70 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

52% less capital inflows, than outflows

Capital inflows: $6.53M | Capital outflows: $13.5M

85% less call options, than puts

Call options by funds: $145K | Put options by funds: $957K

Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
31
Reduced
13
Closed
11
Calls
$145​K
Puts
$957​K
Net Calls
-⁠$812​K
Net Calls Change
-⁠$933​K

DSCI Hedge Fund Activity: Q3 2014 in Review

70 of the 3,454 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences (DSCI) for Q3 2014, worth a combined $176M — down 30% from $251M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of DSCI and 8 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 31 added.

The largest buyer was Senvest Management, adding an estimated $1.92M. The largest seller was Redmile Group, exiting entirely with an estimated $6.94M sold.

  • 70 institutional investors held Derma Sciences (DSCI) as of Q3 2014, down from 73 in Q2 2014.
  • Funds reported $176M of Derma Sciences stock for Q3 2014, down 30% quarter-over-quarter.
  • 8 funds opened new Derma Sciences positions in Q3 2014 and 11 closed out, a net change of -3 holders.
  • The largest Derma Sciences buyer in Q3 2014 was Senvest Management, an estimated $1.92M added.
  • The largest Derma Sciences seller in Q3 2014 was Redmile Group, an estimated $6.94M sold.

Based on aggregated 13F filings for Q3 2014.